SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Accession No. 0001193125-09-102866
Filing Date
2009-05-07
Accepted
2009-05-07 11:36:04
Documents
15
Period of Report
2009-05-07
Filing Date Changed
2009-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 391734
  Complete submission text file 0001193125-09-102866.txt   1496111

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT teva-20090331.xml EX-101.INS 225685
3 XBRL TAXONOMY EXTENSION SCHEMA teva-20090331.xsd EX-101.SCH 7169
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20090331_cal.xml EX-101.CAL 34755
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20090331_lab.xml EX-101.LAB 75761
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20090331_pre.xml EX-101.PRE 62003
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-16174 | Film No.: 09804181
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1